Vice President of M&A Advisory at IQVIA, Massimiliano has deep expertise in evaluating healthcare investments (pharma, biotech, medtech, consumer health, and services), having analyzed hundreds of deals across Europe, the Middle East, and India over the past 25 years. His contribution to the Investment Committee is instrumental in understanding the key value drivers of initiatives in this sector.